tiprankstipranks
Trending News
More News >
Cadrenal Therapeutics, Inc. (CVKD)
:CVKD
US Market

Cadrenal Therapeutics, Inc. (CVKD) Income Statement

Compare
405 Followers

Cadrenal Therapeutics, Inc. Income Statement

Last quarter (Q3 2025), Cadrenal Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Cadrenal Therapeutics, Inc.'s net income was $-2.69M. See Cadrenal Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22
Total Revenue
$ 0.00$ 0.00$ 0.00
Gross Profit
$ -1.88K$ 0.00$ -1.27K
Operating Expenses
$ 10.96M$ 7.63M$ 2.70M
Depreciation and Amortization
$ 1.88K$ 1.98K$ 1.27K
EBITDA
$ -10.65M$ -8.34M$ -6.61M
Operating Income
$ -10.96M$ -7.63M$ -2.70M
Other Income/Expenses
$ 309.25K$ -724.24K$ -4.01M
Pretax Income
$ -10.65M$ -8.36M$ -6.71M
Net Income
$ -10.65M$ -8.36M$ -6.71M
Per Share Metrics
Basic EPS
$ -8.73$ -9.63$ -8.66
Diluted EPS
$ -8.73$ -9.63$ -8.66
Weighted Average Shares Outstanding
1.22M 868.18K 775.64K
Weighted Average Shares Outstanding (Diluted)
1.22M 868.18K 775.64K
Currency in USD

Cadrenal Therapeutics, Inc. Earnings and Revenue History